AnalysisNews

ELTP today

$0.39+$0.02 (+4.08%)close Jun 25, 2026

Trend

—

Key levels

—

Latest news & SEC filings

SEC FilingNov 3, 2026Elite Pharmaceuticals Inc filed a report on a major company event (Form 8-K)

SEC FilingOct 19, 2026Elite Pharmaceuticals Inc filed an insider trading report (Form 4)

All ELTP news →

OTC · Healthcare

ELITE PHARMACEUTICALS INC /NV/ (ELTP)

$0.39+0.02 (+4.08%)
WATCHLISTGrade: C+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
0.360.380.400.420.39May 21Jun 1Jun 9Jun 17
High0.40
Low0.36
Open0.36
Volume388K
Avg Vol568K
VWAP0.37
30d High0.43
30d Low0.34
30d Chg+10.79%
See full chart with real-time data

What Is the Price Target for ELTP?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.39Upside: +0.0%Confidence: 20%Method: No Coverage

Is ELTP a Buy or Sell Right Now?

53
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 77.1% YoY with ACCELERATING trend — accelerating momentum.
  • •SEC filings signal active product innovation — 2 new product/expansion keywords detected in 10-K. R&D investment stable.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ELTP.

Start Free Trial →

Is ELTP Overvalued or Undervalued?

Valuation Verdict

OVERVALUED

Methods Used

P/B

Fair Value

$0.22

29

Moat Score

NONE

5/9

Piotroski Score

7.2

Altman Z-Score

What Is Smart Money Doing with ELTP?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

ACCUMULATING

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

ELTP Growth Story

Revenue YoY

77.1%

3yr Revenue CAGR

N/A%

EPS Growth YoY

N/A

FCF Growth YoY

291.4%

Revenue Trend

ACCELERATING

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for ELITE PHARMACEUTICALS INC /NV/ (ELTP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

Sign Up Free — Download AI Report PDF →

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

Compare SEPT with other platforms

SEPT vs TradingViewSEPT vs BloombergSEPT vs Unusual WhalesSEPT vs SpotGammaSEPT vs TrendSpiderAI Trading Platforms Compared
What is dark pool trading?How to read options flowGEX explainedSmart money trackingAI stock analysisEarn money on SEPT

About SEPT Investing

SEPT Investing tracks 13,000+ stocks with live charts, trend and key-level tracking, dark pool and options flow, insider and congress trades, SEC filings and news alerts.

Disclaimer: This page is for informational purposes only. It does not constitute financial advice. Past performance does not guarantee future results. Always do your own research before making investment decisions.

ELTP — frequently asked questions

What is ELTP stock price today?

ELITE PHARMACEUTICALS INC /NV/ (ELTP) is at $0.39, up 4.08% (+$0.02) at the Jun 25, 2026 close.

Why is ELTP stock moving today?

Latest ELTP news — Nov 3, 2026: Elite Pharmaceuticals Inc filed a report on a major company event (Form 8-K) · Oct 19, 2026: Elite Pharmaceuticals Inc filed an insider trading report (Form 4)

Did ELTP beat earnings?

ELTP last reported on Aug 13, 2026: EPS $0.01.

Does ELTP pay a dividend?

ELTP does not currently pay a dividend.

What are insiders doing with ELTP?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on ELTP?

Nov 3, 2026: Elite Pharmaceuticals Inc filed a report on a major company event (Form 8-K) · Oct 19, 2026: Elite Pharmaceuticals Inc filed an insider trading report (Form 4)